Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle & Vision Summit
Rhea-AI Summary
Vanda Pharmaceuticals (Nasdaq: VNDA) announced it will participate in a fireside chat at the B. Riley Securities Mind, Muscle & Vision Summit in Boston, Massachusetts. The appearance is scheduled for Thursday, July 16, 2026, as part of the summit program.
Positive
- None.
Negative
- None.
News Market Reaction – VNDA
In the Jul 13 session, VNDA declined 3.85%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 07 | Regulatory designation | Positive | +3.0% | FDA rare pediatric disease designation for VCA-894A in CMT2S. |
| May 27 | Regulatory designation | Positive | +3.9% | Japan orphan drug designation for imsidolimab in GPP. |
| May 07 | Investor conferences | Neutral | -1.7% | Announcement of participation in multiple May 2026 investor events. |
| May 06 | Earnings report | Negative | -14.1% | Q1 2026 results with GAAP net loss and guidance update. |
| May 04 | Product launch | Positive | +8.0% | U.S. commercial availability of NEREUS for motion sickness. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
VNDA has tended to trade higher on positive regulatory or product milestones but sold off sharply around its latest earnings report.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-b-riley-securities-2026-mind-muscle--vision-summit-302823067.html
SOURCE Vanda Pharmaceuticals Inc.